News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,635 Results
Type
Article (42327)
Company Profile (296)
Press Release (688001)
Multimedia
Podcasts (93)
Webinars (18)
Section
Business (206919)
Career Advice (2030)
Deals (35874)
Drug Delivery (113)
Drug Development (82746)
Employer Resources (173)
FDA (16593)
Job Trends (15102)
News (350386)
Policy (32994)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2612)
Accelerated approval (35)
Adcomms (29)
Allergies (146)
Alliances (50386)
ALS (172)
Alzheimer's disease (1683)
Antibody-drug conjugate (ADC) (339)
Approvals (16856)
Artificial intelligence (541)
Autoimmune disease (164)
Automation (43)
Bankruptcy (362)
Best Places to Work (11772)
BIOSECURE Act (20)
Biosimilars (194)
Biotechnology (198)
Bladder cancer (165)
Brain cancer (63)
Breast cancer (665)
Cancer (5053)
Cardiovascular disease (407)
Career advice (1715)
Career pathing (37)
CAR-T (294)
CDC (48)
Celiac Disease (2)
Cell therapy (768)
Cervical cancer (38)
Clinical research (70741)
Collaboration (1772)
Company closure (4)
Compensation (1188)
Complete response letters (59)
COVID-19 (2727)
CRISPR (95)
C-suite (884)
Cystic fibrosis (144)
Data (6380)
Decentralized trials (2)
Denatured (29)
Depression (136)
Diabetes (505)
Diagnostics (6795)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (267)
Drug pricing (186)
Drug shortages (28)
Duchenne muscular dystrophy (234)
Earnings (90849)
Editorial (60)
Employer branding (21)
Employer resources (152)
Events (119482)
Executive appointments (1004)
FDA (19782)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1495)
Gene editing (203)
Generative AI (49)
Gene therapy (606)
GLP-1 (978)
Government (4700)
Grass and pollen (6)
Guidances (384)
Healthcare (19124)
HIV (63)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (261)
Immuno-oncology (68)
Indications (121)
Infectious disease (3007)
Inflammatory bowel disease (198)
Inflation Reduction Act (14)
Influenza (120)
Intellectual property (256)
Interviews (316)
IPO (16777)
IRA (51)
Job creations (3670)
Job search strategy (1432)
JPM (62)
Kidney cancer (17)
Labor market (86)
Layoffs (566)
Leadership (32)
Legal (7982)
Liver cancer (95)
Longevity (15)
Lung cancer (689)
Lymphoma (386)
Machine learning (42)
Management (59)
Manufacturing (814)
MASH (165)
Medical device (13830)
Medtech (13888)
Mergers & acquisitions (20182)
Metabolic disorders (1282)
Multiple sclerosis (165)
NASH (16)
Neurodegenerative disease (325)
Neuropsychiatric disorders (89)
Neuroscience (2940)
Neurotech (1)
NextGen: Class of 2026 (6585)
Non-profit (4550)
Now hiring (68)
Obesity (603)
Opinion (271)
Ovarian cancer (169)
Pain (204)
Pancreatic cancer (242)
Parkinson's disease (287)
Partnered (33)
Patents (512)
Patient recruitment (506)
Peanut (58)
People (59673)
Pharmaceutical (66)
Pharmacy benefit managers (30)
Phase 1 (22118)
Phase 2 (31107)
Phase 3 (23203)
Pipeline (5543)
Policy (292)
Postmarket research (2595)
Preclinical (9345)
Press Release (64)
Prostate cancer (248)
Psychedelics (49)
Radiopharmaceuticals (296)
Rare diseases (857)
Real estate (6016)
Recruiting (70)
Regulatory (24828)
Reports (53)
Research institute (2444)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (18)
RSV (81)
Schizophrenia (152)
Series A (245)
Series B (194)
Service/supplier (11)
Sickle cell disease (100)
Special edition (23)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3683)
State (2)
Stomach cancer (20)
Supply chain (105)
Tariffs (85)
The Weekly (62)
Vaccines (1026)
Venture capital (93)
Weight loss (387)
Women's health (96)
Worklife (18)
Date
Today (153)
Last 7 days (684)
Last 30 days (2391)
Last 365 days (30303)
2026 (4197)
2025 (30589)
2024 (35672)
2023 (40497)
2022 (51696)
2021 (56233)
2020 (54539)
2019 (47056)
2018 (35455)
2017 (32656)
2016 (32028)
2015 (38065)
2014 (31750)
2013 (26719)
2012 (28926)
2011 (29660)
2010 (27611)
Location
Africa (746)
Alabama (90)
Alaska (7)
Arizona (312)
Arkansas (13)
Asia (40033)
Australia (6547)
California (11506)
Canada (3331)
China (1134)
Colorado (484)
Connecticut (486)
Delaware (341)
Europe (87400)
Florida (1726)
Georgia (363)
Hawaii (3)
Idaho (62)
Illinois (890)
India (72)
Indiana (530)
Iowa (22)
Japan (442)
Kansas (128)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1416)
Massachusetts (8334)
Michigan (328)
Minnesota (638)
Mississippi (5)
Missouri (130)
Montana (34)
Nebraska (28)
Nevada (124)
New Hampshire (79)
New Jersey (3051)
New Mexico (28)
New York (3029)
North Carolina (1481)
North Dakota (8)
Northern California (5623)
Ohio (341)
Oklahoma (21)
Oregon (41)
Pennsylvania (2324)
Puerto Rico (24)
Rhode Island (48)
South America (1120)
South Carolina (68)
South Dakota (1)
Southern California (4486)
Tennessee (178)
Texas (1772)
United States (40878)
Utah (340)
Vermont (1)
Virginia (266)
Washington D.C. (81)
Washington State (935)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
730,635 Results for "aktis oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IPO
UPDATE: Aktis To Become First Biotech IPO of 2026 With $318M Debut
Eli Lilly has expressed interest in participating in the IPO, with the regulatory filing revealing the obesity juggernaut’s plans to buy as much as $100 million worth of Aktis shares.
January 8, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 13, 2026
·
3 min read
Press Releases
AKTIS ONCOLOGY APPOINTS KYLE KUVALANKA CHIEF FINANCIAL OFFICER
November 5, 2025
·
3 min read
Press Releases
Aktis Oncology to Participate in Upcoming September 2025 Investor Conferences
September 10, 2025
·
2 min read
Press Releases
Aktis Oncology Appoints Accomplished Life Sciences Industry Veteran Mike Sherman to its Board of Directors
August 8, 2025
·
3 min read
IPO
2026 IPO Train Keeps Chugging as AgomAb, SpyGlass Eye Nasdaq Debut
Two more biopharma companies—the hair-growth specialist Veradermics and cancer-focused Eikon Therapeutics—have announced their IPOs this year. Meanwhile, Aktis Oncology began trading publicly earlier this month.
January 19, 2026
·
2 min read
·
Tristan Manalac
Business
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER
Aktis Oncology today announced the promotion of Tyler Benedum, Ph.D., to Chief Technical Officer, effective immediately.
May 30, 2024
·
3 min read
Press Releases
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
February 18, 2026
·
5 min read
Business
Aktis Oncology Enters Into Strategic Collaboration With Lilly to Discover and Develop Novel Anticancer Radiopharmaceuticals
Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid tumors, announced a multi-target discovery collaboration agreement with Eli Lilly and Company to generate anticancer radiopharmaceuticals using Aktis Oncology’s novel miniprotein technology platform.
May 21, 2024
·
3 min read
Press Releases
Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
February 13, 2026
·
11 min read
1 of 73,064
Next
